[go: up one dir, main page]

FR2320089A1 - COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION - Google Patents

COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION

Info

Publication number
FR2320089A1
FR2320089A1 FR7623930A FR7623930A FR2320089A1 FR 2320089 A1 FR2320089 A1 FR 2320089A1 FR 7623930 A FR7623930 A FR 7623930A FR 7623930 A FR7623930 A FR 7623930A FR 2320089 A1 FR2320089 A1 FR 2320089A1
Authority
FR
France
Prior art keywords
preparation process
magnesium salts
composition based
therapeutic application
organic calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7623930A
Other languages
French (fr)
Other versions
FR2320089B1 (en
Inventor
Vasile Georgescu
Constantin Fluorescu
Maria Dascalita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva SA
Original Assignee
Intreprinderea de Medicamente Bucuresti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreprinderea de Medicamente Bucuresti filed Critical Intreprinderea de Medicamente Bucuresti
Publication of FR2320089A1 publication Critical patent/FR2320089A1/en
Application granted granted Critical
Publication of FR2320089B1 publication Critical patent/FR2320089B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7623930A 1975-08-05 1976-08-05 COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION Granted FR2320089A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO7583091A RO68298A2 (en) 1975-08-05 1975-08-05 COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS EASILY ASSIMILABLE WITH INCREASED SOLUBILITY AND THE PREPARATION PROCESS

Publications (2)

Publication Number Publication Date
FR2320089A1 true FR2320089A1 (en) 1977-03-04
FR2320089B1 FR2320089B1 (en) 1978-11-17

Family

ID=20095205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7623930A Granted FR2320089A1 (en) 1975-08-05 1976-08-05 COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION

Country Status (7)

Country Link
JP (1) JPS54122216A (en)
CH (1) CH625503A5 (en)
DE (1) DE2635293A1 (en)
FR (1) FR2320089A1 (en)
GB (1) GB1564135A (en)
IN (1) IN144366B (en)
RO (1) RO68298A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130644A1 (en) * 1983-06-30 1985-01-09 Continental Pharma, Inc. Use of 2-Pentanoylaminoacetic acid and salts thereof
EP0394022A1 (en) * 1989-04-19 1990-10-24 Takeda Chemical Industries, Ltd. Calcium pantothenate composit
EP0432092A1 (en) * 1989-11-23 1991-06-12 Ciba-Geigy Ag Pesticide composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209962B (en) * 2006-12-28 2011-08-24 浙江山下湖珍珠集团股份有限公司 Method for preparing calcium magnesium gluconate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2454164A1 (en) * 1974-11-15 1976-05-26 Tad Pharm Werk Injections against magnesium tetany in ruminants - contg. a basic magnesium salt of acetylglutamic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130644A1 (en) * 1983-06-30 1985-01-09 Continental Pharma, Inc. Use of 2-Pentanoylaminoacetic acid and salts thereof
US4562205A (en) * 1983-06-30 1985-12-31 Continental Pharma Inc. Derivatives of 2-aminoacetic acid
EP0394022A1 (en) * 1989-04-19 1990-10-24 Takeda Chemical Industries, Ltd. Calcium pantothenate composit
EP0432092A1 (en) * 1989-11-23 1991-06-12 Ciba-Geigy Ag Pesticide composition

Also Published As

Publication number Publication date
DE2635293A1 (en) 1977-05-12
JPS54122216A (en) 1979-09-21
FR2320089B1 (en) 1978-11-17
CH625503A5 (en) 1981-09-30
GB1564135A (en) 1980-04-02
RO68298A2 (en) 1980-04-15
JPS5761728B2 (en) 1982-12-25
IN144366B (en) 1978-04-29

Similar Documents

Publication Publication Date Title
LU80081A1 (en) NEW HYDROXYMETHYL-5 OXAZOLIDINONES-2, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2383157B1 (en) CHALCON DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE845551A (en) HETEROARYLBENZOXEPINE-ACETIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION
BE851893A (en) NEW ARYL-3 OXAZOLIDINONES-2, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE827323A (en) NEW DIARYL-1,1 OXADIAZOLE-1 ALKYLAMINES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC USE
BE854268A (en) PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE846452A (en) NEW PYRIMIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2326922A1 (en) NEW PILOCARPINE SALTS AND THEIR PREPARATION PROCESS
FR2458547B2 (en) NOVEL AZOLONES N-ARYLE, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2315925A1 (en) NEW 5-BENZYL-2-OXAZOLIDONE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2327273A1 (en) RAPID CRYSTALLIZATION SEQUENCES COPOLYESTERS, AND THEIR PREPARATION PROCESS
FR2320089A1 (en) COMPOSITION BASED ON ORGANIC CALCIUM AND MAGNESIUM SALTS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2349587A1 (en) 1,3-DIHYDRO-HETEROARYLSPIRO (ISOBENZOFURANNES), THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE854812A (en) BENZENESULFONYLUREES, THEIR PROCESS FOR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2313063A1 (en) PYRROLOTRIAZOLOPYRIMIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
BE866676A (en) BISAMIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE868114A (en) MERCAPTOACETYLAMIDOBENZOYLGLYCINE AND THERAPEUTIC MUCOLYSIS PROCESS
BE826017R (en) PYRIMIDIN-6YL ACETHYDROXAMIC ACIDS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2313075A1 (en) MEDICINAL PRODUCT BASED ON L-PYROGLUTAMYL-L-HISTIDYL-L-PROLINAMIDE OR ITS SALTS
FR2317298A1 (en) NEW LACTONS AND THEIR PREPARATION PROCESS
BE866928A (en) BENZENE-SULFONYL UREES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2330390A2 (en) NEW 1,4-BENZODIOXANES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
LU78873A1 (en) ALKYLTHIO-7,8-DIHYDROXY-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, THEIR PREPARATION PROCESS AND THERAPEUTIC APPLICATION
BE825127A (en) THERAPEUTIC PROCESS
BE860773A (en) MONOCYCLIC BETA-LACTAMES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
ST Notification of lapse